[Pharmacological properties and clinical effects of the antifibrotic agent pirfenidone (Pirespa) for treatment of idiopathic pulmonary fibrosis]

MeSH terms

• Animals
• Anti-Inflammatory Agents, Non-Steroidal / adverse effects
• Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
• Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
• Gastrointestinal Diseases / chemically induced
• Humans
• Idiopathic Pulmonary Fibrosis / drug therapy*
• Photosensitivity Disorders / chemically induced
• Pyridones / adverse effects
• Pyridones / pharmacology*
• Pyridones / therapeutic use*
• Skin Neoplasms / chemically induced